Larvol Delta - Phio-Pharmaceuticals-Announces-Regulatory-Clearance-of-Clinical-Trial-With-PH762-and-AgonOx39s-Tumor-Inltrating-Lymphocytes-AGX148-to-Treat-Solid-Tumors

AGX-148 - AgonOx

PH-762 ACT - Phio Pharma

https://www.prnewswire.com/news-releases/phio-pharmaceuticals-announces-regulatory-clearance-of-clinical-trial-with-ph-762-and-agonoxs-tumor-infiltrating-lymphocytes-agx148-to-treat-solid-tumors-301715648.html

Jan 6, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next